Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine

被引:50
作者
Barrese, Vincenzo [1 ]
Miceli, Francesco [2 ]
Soldovieri, Maria Virginia [3 ]
Ambrosino, Paolo [3 ]
Iannotti, Fabio Arturo [3 ]
Cilio, Maria Roberta [2 ]
Taglialatela, Maurizio [1 ,3 ]
机构
[1] Univ Naples Federico II, Dept Neurosci, Naples, Italy
[2] Bambino Ges Childrens Hosp, IRCCS, Div Neurol, Rome, Italy
[3] Univ Molise, Dept Hlth Sci, Campobasso, Italy
来源
CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS | 2010年 / 2卷
关键词
epilepsy; retigabine; potassium channels; antiepileptic drugs; Kv7; channels;
D O I
10.2147/CPAA.S15369
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the availability of over 20 antiepileptic drugs, about 30% of epileptic patients do not achieve seizure control. Thus, identification of additional molecules targeting novel molecular mechanisms is a primary effort in today's antiepileptic drug research. This paper reviews the pharmacological development of retigabine, an antiepileptic drug with a novel mechanism of action, namely the activation of voltage-gated potassium channels of the Kv7 subfamily. These channels, which act as widespread regulators of intrinsic neuronal excitability and of neurotransmitter-induced network excitability changes, are currently viewed among the most promising targets for anticonvulsant pharmacotherapy. In particular, the present work reviews the pathophysiological role of Kv7 channels in neuronal function, the molecular mechanisms involved in the Kv7 channel-opening action of retigabine, the activity of retigabine in preclinical in vitro and in vivo studies predictive of anticonvulsant activities, and the clinical status of development for this drug as an add-on treatment for pharmacoresistant epilepsy. Particular efforts are devoted to highlighting the potential advantages and disadvantages of retigabine when compared with currently available compounds, in order to provide a comprehensive assessment of its role in therapy for treatment-resistant epilepsies.
引用
收藏
页码:225 / 236
页数:12
相关论文
共 93 条
[1]   Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy [J].
Barton, ME ;
Klein, BD ;
Wolf, HH ;
White, HS .
EPILEPSY RESEARCH, 2001, 47 (03) :217-227
[2]  
Bellini G., 1993, GENEREVIEWS
[3]   The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels [J].
Bentzen, Bo Hjorth ;
Schmitt, Nicole ;
Calloe, Kirstine ;
Brown, William Dalby ;
Grunnet, Morten ;
Olesen, Soren-Peter .
NEUROPHARMACOLOGY, 2006, 51 (06) :1068-1077
[4]   Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009 [J].
Berg, Anne T. ;
Berkovic, Samuel F. ;
Brodie, Martin J. ;
Buchhalter, Jeffrey ;
Cross, J. Helen ;
Boas, Walter van Emde ;
Engel, Jerome ;
French, Jacqueline ;
Glauser, Tracy A. ;
Mathern, Gary W. ;
Moshe, Solomon L. ;
Nordli, Douglas ;
Plouin, Perrine ;
Scheffer, Ingrid E. .
EPILEPSIA, 2010, 51 (04) :676-685
[5]   Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII) [J].
Bialer, M ;
Johannessen, SI ;
Kupferberg, HJ ;
Levy, RH ;
Perucca, E ;
Tomson, T .
EPILEPSY RESEARCH, 2004, 61 (1-3) :1-48
[6]   Progress report on new antiepileptic drugs: A summary of the Ninth Eilat Conference (EILAT IX) [J].
Bialer, Meir ;
Johannessen, Svein I. ;
Levy, Rene H. ;
Perucca, Emilio ;
Tomsone, Torbjorn ;
White, H. Steve .
EPILEPSY RESEARCH, 2009, 83 (01) :1-43
[7]   A potassium channel mutation in neonatal human epilepsy [J].
Biervert, C ;
Schroeder, BC ;
Kubisch, C ;
Berkovic, SF ;
Propping, P ;
Jentsch, TJ ;
Steinlein, OK .
SCIENCE, 1998, 279 (5349) :403-406
[8]   N-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type II [J].
Borlak, Jurgen ;
Gasparic, Antje ;
Locher, Mathias ;
Schupke, Hubert ;
Hermann, Robert .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (06) :711-721
[9]   Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures [J].
Boscia, Francesca ;
Annunziato, Lucio ;
Taglialatela, Maurizio .
NEUROPHARMACOLOGY, 2006, 51 (02) :283-294
[10]   Do we need any more new antiepileptic drugs? [J].
Brodie, MJ .
EPILEPSY RESEARCH, 2001, 45 (1-3) :3-6